1. Home
  2. SAIC vs LNTH Comparison

SAIC vs LNTH Comparison

Compare SAIC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAIC
  • LNTH
  • Stock Information
  • Founded
  • SAIC 1969
  • LNTH 1956
  • Country
  • SAIC United States
  • LNTH United States
  • Employees
  • SAIC N/A
  • LNTH N/A
  • Industry
  • SAIC EDP Services
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • SAIC Technology
  • LNTH Health Care
  • Exchange
  • SAIC Nasdaq
  • LNTH Nasdaq
  • Market Cap
  • SAIC 4.9B
  • LNTH 5.7B
  • IPO Year
  • SAIC N/A
  • LNTH 2015
  • Fundamental
  • Price
  • SAIC $113.21
  • LNTH $70.56
  • Analyst Decision
  • SAIC Buy
  • LNTH Strong Buy
  • Analyst Count
  • SAIC 10
  • LNTH 5
  • Target Price
  • SAIC $131.40
  • LNTH $131.20
  • AVG Volume (30 Days)
  • SAIC 417.0K
  • LNTH 1.1M
  • Earning Date
  • SAIC 09-04-2025
  • LNTH 08-06-2025
  • Dividend Yield
  • SAIC 1.34%
  • LNTH N/A
  • EPS Growth
  • SAIC N/A
  • LNTH N/A
  • EPS
  • SAIC 7.14
  • LNTH 3.53
  • Revenue
  • SAIC $7,509,000,000.00
  • LNTH $1,536,699,000.00
  • Revenue This Year
  • SAIC $4.21
  • LNTH $4.57
  • Revenue Next Year
  • SAIC $2.37
  • LNTH $9.41
  • P/E Ratio
  • SAIC $15.51
  • LNTH $20.24
  • Revenue Growth
  • SAIC 3.39
  • LNTH 12.53
  • 52 Week Low
  • SAIC $94.68
  • LNTH $69.12
  • 52 Week High
  • SAIC $156.34
  • LNTH $118.21
  • Technical
  • Relative Strength Index (RSI)
  • SAIC 51.06
  • LNTH 36.36
  • Support Level
  • SAIC $109.84
  • LNTH $69.45
  • Resistance Level
  • SAIC $116.70
  • LNTH $73.52
  • Average True Range (ATR)
  • SAIC 2.67
  • LNTH 2.37
  • MACD
  • SAIC -0.38
  • LNTH -0.20
  • Stochastic Oscillator
  • SAIC 40.17
  • LNTH 18.49

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: